MS Pace

MS Pace is a healthcare-focused secondaries fund managed by SightLine Partners, a venture capital firm based in Bloomington, Minnesota. The fund specializes in acquiring secondary interests in late-stage medical technology and biotechnology companies, providing liquidity to early investors and founders. MS Pace has been a significant investor in several notable life science companies, including Microchips Biotech (acquired by Daré Bioscience), Itamar Medical, and Earlens Corporation. While operating as an investment vehicle rather than a drug developer, the fund plays a critical role in the financing and maturation of healthcare innovations. The fund is currently closed and its portfolio has largely transitioned through acquisitions or public offerings.